Transdermal Drug Delivery System Market to 2027 - Global Analysis and Forecasts Type (Transdermal Patches and Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications and Others), End User (Hospitals & Clinics, Home Care Settings and Others), and Geography
Report Code: TIPRE00002894 No. of Pages: 150 Category: Medical Device Status: Upcoming
A transdermal drug delivery system are self-contained, self-discrete dosage form that deliver the drugs through the skin portal to systemic circulation at preset rate and maintain clinically the effective concentrations over a prolonged period of time. These systems offer controlled release of the drug into the patient that allow a steady blood level profile that resulting in reduced systemic side effects and helps to improve efficacy over other dosage forms.
The transdermal drug delivery system market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing number of patients suffering from chronic disorders and growing geriatric population. However, increase demand of third-generation transdermal drug delivery systems is anticipated to offer more growth opportunities for the players operating in the transdermal drug delivery system market.
The "Global Transdermal Drug Delivery System Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by type, application, end user, and geography. The global transdermal drug delivery system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading transdermal drug delivery system market players and offers key trends and opportunities in the market.
The global transdermal drug delivery system market is segmented on the basis of type, application, and end user. Based on type, the transdermal drug delivery system market is bifurcated into transdermal patches and transdermal semisolids. The transdermal patches segment is further segmented as, matrix patches, microneedle patches, drug-in-adhesive patches and reservoir membrane patches. The transdermal semisolids segment is also further segmented as, sprays, gels and ointments. On the basis of application, the market is classified as, cardiovascular diseases, central nervous system disorders, pain management, hormonal applications and others. The hormonal applications segment is further bifurcated into, transdermal estrogen therapy and testosterone replacement therapy. Based on the end user, the transdermal drug delivery system market is segmented into hospitals & clinics, home care settings and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global transdermal drug delivery system market based on type, application, and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The transdermal drug delivery system market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the transdermal drug delivery system market in the coming years, due to rise in the number of patients with neurovascular disorders in the region. However, Asia Pacific is expected to witness significant growth in the market during the forecast period, owing to growing concern about painless drug delivery in the region.
The report analyzes factors affecting transdermal drug delivery system market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the transdermal drug delivery system market in these regions.
The report also includes the profiles of key transdermal drug delivery system companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the transdermal drug delivery system market include, Novartis AG, Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Bayer AG, Bristol-Myers Squibb Company, Mylan N.V., Boehringer Ingelheim International GmbH, Lavipharm, Purdue Pharma L.P., Luye Pharma Group and among others.
The transdermal drug delivery system market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing number of patients suffering from chronic disorders and growing geriatric population. However, increase demand of third-generation transdermal drug delivery systems is anticipated to offer more growth opportunities for the players operating in the transdermal drug delivery system market.
The "Global Transdermal Drug Delivery System Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by type, application, end user, and geography. The global transdermal drug delivery system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading transdermal drug delivery system market players and offers key trends and opportunities in the market.
The global transdermal drug delivery system market is segmented on the basis of type, application, and end user. Based on type, the transdermal drug delivery system market is bifurcated into transdermal patches and transdermal semisolids. The transdermal patches segment is further segmented as, matrix patches, microneedle patches, drug-in-adhesive patches and reservoir membrane patches. The transdermal semisolids segment is also further segmented as, sprays, gels and ointments. On the basis of application, the market is classified as, cardiovascular diseases, central nervous system disorders, pain management, hormonal applications and others. The hormonal applications segment is further bifurcated into, transdermal estrogen therapy and testosterone replacement therapy. Based on the end user, the transdermal drug delivery system market is segmented into hospitals & clinics, home care settings and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global transdermal drug delivery system market based on type, application, and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The transdermal drug delivery system market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the transdermal drug delivery system market in the coming years, due to rise in the number of patients with neurovascular disorders in the region. However, Asia Pacific is expected to witness significant growth in the market during the forecast period, owing to growing concern about painless drug delivery in the region.
The report analyzes factors affecting transdermal drug delivery system market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the transdermal drug delivery system market in these regions.
The report also includes the profiles of key transdermal drug delivery system companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the transdermal drug delivery system market include, Novartis AG, Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Bayer AG, Bristol-Myers Squibb Company, Mylan N.V., Boehringer Ingelheim International GmbH, Lavipharm, Purdue Pharma L.P., Luye Pharma Group and among others.
Table of Contents
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Transdermal Drug Delivery System Market- By Type
1.3.2. Transdermal Drug Delivery System Market- By Application
1.3.3. Transdermal Drug Delivery System Market- By End User
1.3.4. Transdermal Drug Delivery System Market- By Region
1.3.4.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis
5. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
?
6. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET- GLOBAL ANALYSIS
6.1. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET - GLOBAL MARKET OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRANSDERMAL PATCHES MARKET
7.3.1. Overview
7.3.2. Transdermal Patches Market Forecast and Analysis (US$ Mn)
7.3.3. Matrix Patches Market
7.3.3.1. Overview
7.3.3.2. Matrix Patches Market Forecast and Analysis (US$ Mn)
7.3.4. Microneedle Patches Market
7.3.4.1. Overview
7.3.4.2. Microneedle Patches Market Forecast and Analysis (US$ Mn)
7.3.5. Drug-In-Adhesive Patches Market
7.3.5.1. Overview
7.3.5.2. Drug-In-Adhesive Patches Market Forecast and Analysis (US$ Mn)
7.3.6. Reservoir Membrane Patches Market
7.3.6.1. Overview
7.3.6.2. Reservoir Membrane Patches Market Forecast and Analysis (US$ Mn)
7.4. TRANSDERMAL SEMISOLIDS MARKET
7.4.1. Overview
7.4.2. Transdermal Semisolids Market Forecast and Analysis (US$ Mn)
7.4.3. Sprays Market
7.4.3.1. Overview
7.4.3.2. Sprays Market Forecast and Analysis (US$ Mn)
?
7.4.4. Gels Market
7.4.4.1. Overview
7.4.4.2. Gels Market Forecast and Analysis (US$ Mn)
7.4.5. Ointments Market
7.4.5.1. Overview
7.4.5.2. Ointments Market Forecast and Analysis (US$ Mn)
8. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOVASCULAR DISEASES MARKET
8.3.1. Overview
8.3.2. Cardiovascular Diseases Market Forecast and Analysis (US$ Mn)
8.4. CENTRAL NERVOUS SYSTEM DISORDERS MARKET
8.4.1. Overview
8.4.2. Central Nervous System Disorders Market Forecast and Analysis (US$ Mn)
8.5. PAIN MANAGEMENT MARKET
8.5.1. Overview
8.5.2. Pain Management Market Forecast and Analysis (US$ Mn)
8.6. HORMONAL APPLICATIONS MARKET
8.6.1. Overview
8.6.2. Hormonal Applications Market Forecast and Analysis (US$ Mn)
8.6.3. Transdermal Estrogen Therapy Market
8.6.3.1. Overview
8.6.3.2. Transdermal Estrogen Therapy Market Forecast and Analysis (US$ Mn)
8.6.4. Testosterone Replacement Therapy Market
8.6.4.1. Overview
8.6.4.2. Testosterone Replacement Therapy Market Forecast and Analysis (US$ Mn)
?
8.7. OTHER APPLICATIONS MARKET
8.7.1. Overview
8.7.2. Other Applications Market Forecast and Analysis (US$ Mn)
9. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
9.1. OVERVIEW
9.2. BY END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS & CLINICS MARKET
9.3.1. Overview
9.3.2. Hospitals & Clinics Market Forecast and Analysis (US$ Mn)
9.4. HOME CARE SETTINGS MARKET
9.4.1. Overview
9.4.2. Home Care Settings Market Forecast and Analysis (US$ Mn)
9.5. OTHER BY END USERS MARKET
9.5.1. Overview
9.5.2. Other By End Users Market Forecast and Analysis (US$ Mn)
10. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.1.1. North America Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.1.2.1. North America Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.1.2.2. North America Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.1.3. North America Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.1.3.1. North America Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.1.4. North America Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.1.5. North America Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.1.1. US Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.1.2. US Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.2. US Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.1.6.2.1. US Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.3. US Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.1.1. Canada Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.1.2. Canada Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.2. Canada Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.1.7.2.1. Canada Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.3. Canada Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.1.1. Mexico Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.1.2. Mexico Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.2. Mexico Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.1.8.2.1. Mexico Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.3. Mexico Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.2. EUROPE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.2.1. Europe Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.2.2.1. Europe Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.2.2.2. Europe Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.2.3. Europe Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.2.3.1. Europe Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.2.4. Europe Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.2.5. Europe Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.1.1. UK Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.1.2. UK Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.2. UK Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.2.6.2.1. UK Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.3. UK Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Canada Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.1.1. Germany Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.1.2. Germany Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.2. Germany Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.2.7.2.1. Germany Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.3. Germany Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.1.1. France Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.1.2. France Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.2. France Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.2.8.2.1. France Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.3. France Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.3. ASIA PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.3.1. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.3.2.1. Asia Pacific Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.3.2.2. Asia Pacific Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.3.3. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.3.3.1. Asia Pacific Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.3.4. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.3.5. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.3.6. Japan Market Overview
10.3.6.1. Japan Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.1.1. Japan Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.1.2. Japan Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.2. Japan Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.3.6.2.1. Japan Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.3. Japan Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.3.7. India Market Overview
10.3.7.1. India Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.1.1. India Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.1.2. India Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.2. India Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.3.7.2.1. India Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.3. India Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.3.8. China Market Overview
10.3.8.1. China Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.1.1. China Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.1.2. China Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.2. China Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.3.8.2.1. China Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.3. China Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.4. MIDDLE EAST & AFRICA (MEA) TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.4.1. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.4.2.1. Middle East & Africa (MEA) Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.4.2.2. Middle East & Africa (MEA) Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.4.3. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.4.3.1. Middle East & Africa (MEA) Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.4.4. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.4.5. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.4.6. South Africa Market Overview
10.4.6.1. South Africa Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.1.1. South Africa Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.1.2. South Africa Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.2. South Africa Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.4.6.2.1. South Africa Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.3. South Africa Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.1.1. Saudi Arabia Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.1.2. Saudi Arabia Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.2. Saudi Arabia Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.4.7.2.1. Saudi Arabia Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.3. Saudi Arabia Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.4.8. UAE Market Overview
10.4.8.1. UAE Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.1.1. UAE Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.1.2. UAE Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.2. UAE Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.4.8.2.1. UAE Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.3. UAE Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.5.1. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.5.2.1. South and Central America Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.5.2.2. South and Central America Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.5.3. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.5.3.1. South and Central America Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.5.4. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.5.5. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.1.1. Brazil Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.1.2. Brazil Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.2. Brazil Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.5.6.2.1. Brazil Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.3. Brazil Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions
12. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JOHNSON & JOHNSON SERVICES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BRISTOL-MYERS SQUIBB COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYLAN N.V.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LAVIPHARM
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PURDUE PHARMA L.P.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LUYE PHARMA GROUP
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Transdermal Drug Delivery System Market- By Type
1.3.2. Transdermal Drug Delivery System Market- By Application
1.3.3. Transdermal Drug Delivery System Market- By End User
1.3.4. Transdermal Drug Delivery System Market- By Region
1.3.4.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis
5. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
?
6. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET- GLOBAL ANALYSIS
6.1. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET - GLOBAL MARKET OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRANSDERMAL PATCHES MARKET
7.3.1. Overview
7.3.2. Transdermal Patches Market Forecast and Analysis (US$ Mn)
7.3.3. Matrix Patches Market
7.3.3.1. Overview
7.3.3.2. Matrix Patches Market Forecast and Analysis (US$ Mn)
7.3.4. Microneedle Patches Market
7.3.4.1. Overview
7.3.4.2. Microneedle Patches Market Forecast and Analysis (US$ Mn)
7.3.5. Drug-In-Adhesive Patches Market
7.3.5.1. Overview
7.3.5.2. Drug-In-Adhesive Patches Market Forecast and Analysis (US$ Mn)
7.3.6. Reservoir Membrane Patches Market
7.3.6.1. Overview
7.3.6.2. Reservoir Membrane Patches Market Forecast and Analysis (US$ Mn)
7.4. TRANSDERMAL SEMISOLIDS MARKET
7.4.1. Overview
7.4.2. Transdermal Semisolids Market Forecast and Analysis (US$ Mn)
7.4.3. Sprays Market
7.4.3.1. Overview
7.4.3.2. Sprays Market Forecast and Analysis (US$ Mn)
?
7.4.4. Gels Market
7.4.4.1. Overview
7.4.4.2. Gels Market Forecast and Analysis (US$ Mn)
7.4.5. Ointments Market
7.4.5.1. Overview
7.4.5.2. Ointments Market Forecast and Analysis (US$ Mn)
8. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOVASCULAR DISEASES MARKET
8.3.1. Overview
8.3.2. Cardiovascular Diseases Market Forecast and Analysis (US$ Mn)
8.4. CENTRAL NERVOUS SYSTEM DISORDERS MARKET
8.4.1. Overview
8.4.2. Central Nervous System Disorders Market Forecast and Analysis (US$ Mn)
8.5. PAIN MANAGEMENT MARKET
8.5.1. Overview
8.5.2. Pain Management Market Forecast and Analysis (US$ Mn)
8.6. HORMONAL APPLICATIONS MARKET
8.6.1. Overview
8.6.2. Hormonal Applications Market Forecast and Analysis (US$ Mn)
8.6.3. Transdermal Estrogen Therapy Market
8.6.3.1. Overview
8.6.3.2. Transdermal Estrogen Therapy Market Forecast and Analysis (US$ Mn)
8.6.4. Testosterone Replacement Therapy Market
8.6.4.1. Overview
8.6.4.2. Testosterone Replacement Therapy Market Forecast and Analysis (US$ Mn)
?
8.7. OTHER APPLICATIONS MARKET
8.7.1. Overview
8.7.2. Other Applications Market Forecast and Analysis (US$ Mn)
9. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
9.1. OVERVIEW
9.2. BY END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS & CLINICS MARKET
9.3.1. Overview
9.3.2. Hospitals & Clinics Market Forecast and Analysis (US$ Mn)
9.4. HOME CARE SETTINGS MARKET
9.4.1. Overview
9.4.2. Home Care Settings Market Forecast and Analysis (US$ Mn)
9.5. OTHER BY END USERS MARKET
9.5.1. Overview
9.5.2. Other By End Users Market Forecast and Analysis (US$ Mn)
10. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.1.1. North America Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.1.2.1. North America Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.1.2.2. North America Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.1.3. North America Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.1.3.1. North America Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.1.4. North America Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.1.5. North America Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.1.1. US Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.1.2. US Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.2. US Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.1.6.2.1. US Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.3. US Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.1.1. Canada Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.1.2. Canada Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.2. Canada Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.1.7.2.1. Canada Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.3. Canada Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.1.1. Mexico Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.1.2. Mexico Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.2. Mexico Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.1.8.2.1. Mexico Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.3. Mexico Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.2. EUROPE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.2.1. Europe Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.2.2.1. Europe Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.2.2.2. Europe Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.2.3. Europe Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.2.3.1. Europe Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.2.4. Europe Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.2.5. Europe Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.1.1. UK Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.1.2. UK Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.2. UK Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.2.6.2.1. UK Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.3. UK Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Canada Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.1.1. Germany Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.1.2. Germany Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.2. Germany Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.2.7.2.1. Germany Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.3. Germany Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.1.1. France Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.1.2. France Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.2. France Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.2.8.2.1. France Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.3. France Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.3. ASIA PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.3.1. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.3.2.1. Asia Pacific Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.3.2.2. Asia Pacific Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.3.3. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.3.3.1. Asia Pacific Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.3.4. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.3.5. Asia Pacific Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.3.6. Japan Market Overview
10.3.6.1. Japan Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.1.1. Japan Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.1.2. Japan Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.2. Japan Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.3.6.2.1. Japan Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.3. Japan Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.3.7. India Market Overview
10.3.7.1. India Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.1.1. India Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.1.2. India Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.2. India Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.3.7.2.1. India Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.3. India Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.3.8. China Market Overview
10.3.8.1. China Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.1.1. China Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.1.2. China Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.2. China Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.3.8.2.1. China Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.3. China Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.4. MIDDLE EAST & AFRICA (MEA) TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.4.1. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.4.2.1. Middle East & Africa (MEA) Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.4.2.2. Middle East & Africa (MEA) Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.4.3. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.4.3.1. Middle East & Africa (MEA) Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.4.4. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.4.5. Middle East & Africa (MEA) Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.4.6. South Africa Market Overview
10.4.6.1. South Africa Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.1.1. South Africa Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.1.2. South Africa Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.2. South Africa Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.4.6.2.1. South Africa Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.3. South Africa Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.1.1. Saudi Arabia Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.1.2. Saudi Arabia Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.2. Saudi Arabia Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.4.7.2.1. Saudi Arabia Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.3. Saudi Arabia Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.4.8. UAE Market Overview
10.4.8.1. UAE Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.1.1. UAE Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.1.2. UAE Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.2. UAE Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.4.8.2.1. UAE Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.3. UAE Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.5.1. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.5.2.1. South and Central America Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.5.2.2. South and Central America Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.5.3. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis - By Application (US$ Mn)
10.5.3.1. South and Central America Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.5.4. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis - By End User (US$ Mn)
10.5.5. South and Central America Transdermal Drug Delivery System Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Transdermal Drug Delivery System Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.1.1. Brazil Traditional Transdermal Patches Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.1.2. Brazil Traditional Transdermal Semisolids Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.2. Brazil Transdermal Drug Delivery System Market By Forecasts and Analysis - By Application (US$ Mn)
10.5.6.2.1. Brazil Traditional Hormonal Applications Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.3. Brazil Transdermal Drug Delivery System Market By Forecasts and Analysis - By End User (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions
12. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JOHNSON & JOHNSON SERVICES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BRISTOL-MYERS SQUIBB COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYLAN N.V.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LAVIPHARM
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PURDUE PHARMA L.P.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LUYE PHARMA GROUP
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Novartis AG
2. Johnson & Johnson Services, Inc.
3. GlaxoSmithKline plc.
4. Bayer AG
5. Bristol-Myers Squibb Company
6. Mylan N.V.
7. Boehringer Ingelheim International GmbH
8. Lavipharm
9. Purdue Pharma L.P.
10. Luye Pharma Group
1. Novartis AG
2. Johnson & Johnson Services, Inc.
3. GlaxoSmithKline plc.
4. Bayer AG
5. Bristol-Myers Squibb Company
6. Mylan N.V.
7. Boehringer Ingelheim International GmbH
8. Lavipharm
9. Purdue Pharma L.P.
10. Luye Pharma Group